Article
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma
21 Oct 2016
Abstract excerpt
BACKGROUND: Hepatocellular carcinoma (HCC) has very high prevalence and associated-mortality. However, targeted therapies that are currently used in clinical practice for HCC have certain limitations, in part because of the lack of reliable and clinically applicable biomarkers that can be used for diagnosis and prognosis assessments and for the surveillance of treatment effectiveness. METHODS: AQueous One...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
